Additionally, topical curcumin treatment demonstrated inhibition of the inflammatory IL-23/IL-17 axis (pathogenic drivers of psoriatic disease) and other inflammatory cytokines (p < 0.05) in a mouse model of psoriasis [88]. The gene discussed is IL17A; the disease is psoriasis.